Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy

Crescenzo, Francesco; Marastoni, Damiano; Bovo, Chiara; Calabrese, Massimiliano

doi:10.1016/j.msard.2020.102372

Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and severity of COVID-19 (confirmed and possible) in pwMS followed at the Veneto Regional MS Center in Verona (Italy), an area most stricken by COVID-19. In our sample size, the prevalence of COVID-19 seems to be much higher than that officially reported at the regional level on the general population, but it also characterized by a favourable course.

Titolo:	Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
Autori:	CRESCENZO, FRANCESCO MARASTONI, DAMIANO Bovo, Chiara CALABRESE, Massimiliano (Corresponding) mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2020
Rivista:	MULTIPLE SCLEROSIS AND RELATED DISORDERS
Handle:	http://hdl.handle.net/11562/1021771
Appare nelle tipologie:	01.01 Articolo in Rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11562/1021771

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CATALOGO DEI PRODOTTI DELLA RICERCA

File in questo prodotto: